The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...
When pathogens enter our cells as part of an infection, our body will trigger a programmed cell death known as "pyroptosis" ...
The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.
15h
Sugars on immune cells, not just blood vessel walls, may regulate the inflammatory disease process
New research has updated the understanding of how sugars, known as glycans, help immune cells move into the skin in the ...
Tumors were eradicated in 30% of mice receiving cGAS LNPs injected into the tumor, in combination with immune checkpoint blockade.
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...
Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...
Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' ...
to protein-construction sites where the complex molecules that do most of the work in cells get made. mRNA also performs ...
The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback